126902-09-8Relevant academic research and scientific papers
Catalytic Enantioselective Pyridine N-Oxidation
Hsieh, Sheng-Ying,Tang, Yu,Crotti, Simone,Stone, Elizabeth A.,Miller, Scott J.
, p. 18624 - 18629 (2019)
The catalytic, enantioselective N-oxidation of substituted pyridines is described. The approach is predicated on a biomolecule-inspired catalytic cycle wherein high levels of asymmetric induction are provided by aspartic-acid-containing peptides as the aspartyl side chain shuttles between free acid and peracid forms. Desymmetrizations of bis(pyridine) substrates bearing a remote pro-stereogenic center substituted with a group capable of hydrogen bonding to the catalyst are demonstrated. Our approach presents a new entry into chiral pyridine frameworks in a heterocycle-rich molecular environment. Representative functionalizations of the enantioenriched pyridine N-oxides further document the utility of this approach. Demonstration of the asymmetric N-oxidation in two venerable drug-like scaffolds, Loratadine and Varenicline, show the likely generality of the method for highly variable and distinct chiral environments, while also revealing that the approach is applicable to both pyridines and 1,4-pyrazines.
Peptide-Catalyzed Fragment Couplings that Form Axially Chiral Non-C2-Symmetric Biaryls
Coombs, Gavin,Sak, Marcus H.,Miller, Scott J.
, p. 2875 - 2880 (2020/01/24)
We have demonstrated that small, modular, tetrameric peptides featuring the Lewis-basic residue β-dimethylaminoalanine (Dmaa) are capable of atroposelectively coupling naphthols and ester-bearing quinones to yield non-C2-symmetric BINOL-type scaffolds with good yields and enantioselectivity. The study culminates in the asymmetric synthesis of backbone-substituted scaffolds similar to 3,3′-disubstituted BINOLs, such as (R)-TRIP, with good (94:6 e.r.) to excellent (>99.9:0.1 e.r.) enantioselectivity after recrystallization, and a diastereoselective net arylation of the minimally modified nonsteroidal anti-inflammatory drug (NSAID) naproxen.
Diversity of Secondary Structure in Catalytic Peptides with β-Turn-Biased Sequences
Metrano, Anthony J.,Abascal, Nadia C.,Mercado, Brandon Q.,Paulson, Eric K.,Hurtley, Anna E.,Miller, Scott J.
supporting information, p. 492 - 516 (2017/02/23)
X-ray crystallography has been applied to the structural analysis of a series of tetrapeptides that were previously assessed for catalytic activity in an atroposelective bromination reaction. Common to the series is a central Pro-Xaa sequence, where Pro is either l- or d-proline, which was chosen to favor nucleation of canonical β-turn secondary structures. Crystallographic analysis of 35 different peptide sequences revealed a range of conformational states. The observed differences appear not only in cases where the Pro-Xaa loop-region is altered, but also when seemingly subtle alterations to the flanking residues are introduced. In many instances, distinct conformers of the same sequence were observed, either as symmetry-independent molecules within the same unit cell or as polymorphs. Computational studies using DFT provided additional insight into the analysis of solid-state structural features. Select X-ray crystal structures were compared to the corresponding solution structures derived from measured proton chemical shifts, 3J-values, and 1H-1H-NOESY contacts. hese findings imply that the conformational space available to simple peptide-based catalysts is more diverse than precedent might suggest. The direct observation of multiple ground state conformations for peptides of this family, as well as the dynamic processes associated with conformational equilibria, underscore not only the challenge of designing peptide-based catalysts, but also the difficulty in predicting their accessible transition states. These findings implicate the advantages of low-barrier interconversions between conformations of peptide-based catalysts for multistep, enantioselective reactions.
Structural studies of β-turn-containing peptide catalysts for atroposelective quinazolinone bromination
Metrano,Abascal,Mercado,Paulson,Miller
supporting information, p. 4816 - 4819 (2016/04/09)
We describe herein a crystallographic and NMR study of the secondary structural attributes of a β-turn-containing tetra-peptide, Boc-Dmaa-d-Pro-Acpc-Leu-NMe2, which was recently reported as a highly effective catalyst in the atroposelective bromination of 3-arylquinazolin-4(3H)-ones. Inquiries pertaining to the functional consequences of residue substitutions led to the discovery of a more selective catalyst, Boc-Dmaa-d-Pro-Acpc-Leu-OMe, the structure of which was also explored. This new lead catalyst was found to exhibit a type I′ β-turn secondary structure both in the solid state and in solution, a structure that was shown to be an accessible conformation of the previously reported catalyst, as well.
Enantioselective Synthesis of 3-Arylquinazolin-4(3H)-ones via Peptide-Catalyzed Atroposelective Bromination
Diener, Matthew E.,Metrano, Anthony J.,Kusano, Shuhei,Miller, Scott J.
, p. 12369 - 12377 (2015/10/12)
We report the development of a tertiary amine-containing β-turn peptide that catalyzes the atroposelective bromination of pharmaceutically relevant 3-arylquinazolin-4(3H)-ones (quinazolinones) with high levels of enantioinduction over a broad substrate scope. The structure of the free catalyst and the peptide-substrate complex were explored using X-ray crystallography and 2D-NOESY experiments. Quinazolinone rotational barriers about the chiral anilide axis were also studied using density functional theory calculations and are discussed in light of the high enantioselectivities observed. Mechanistic studies also suggest that the initial bromination event is stereodetermining, and the major monobromide intermediate is an atropisomerically stable, mono-ortho-substituted isomer. The observation of stereoisomerically stable monobromides stimulated the conversion of the tribromide products to other atropisomerically defined products of interest. For example, (1) a dehalogenation Suzuki-Miyaura cross-coupling sequence delivers ortho-arylated derivatives, and (2) a regioselective Buchwald-Hartwig amination procedure installs para-amine functionality. Stereochemical information was retained during these subsequent transformations.
Latent inhibitors part 10. The inhibition of carboxypeptidase A by tetrapeptide analogues based on 1-aminocyclopropane carboxylic acid
Husbands,Suckling,Suckling
, p. 9729 - 9742 (2007/10/02)
In order to test the phenomenon of substrate activation of irreversible inhibition of carboxypeptidase A, extended inhibitors were designed. The synthesis of two N-protected tetrapeptide analogues containing C-terminal sulphones and 1-aminocyclopropane carboxylic acid and one similar N-unprotected tetrapeptide with C-terminal phenylalanine is described. The compounds were evaluated as inhibitors of carboxypeptidase a. The tetrapeptide sulphones exhibited time-dependent inhibition following the unusual 'substrate activated' pattern of related dipeptides but the phenylalanine containing dipeptide behaved as a mixed non-competitive inhibitor. A molecular modelling evaluation of the potential of aminocyclopropane carboxylic acid derivatives to act as irreversible inhibitors of peptidases was undertaken in an attempt to identify the properties of such compounds that lead to the unusual kinetic properties. A mechanism for the inhibition reactions of dipeptide and tetrapeptide analogues is proposed.
Stereochemistry of Cyclic Dipeptides. Assignment of the Prochiral Methylenes of 1-Aminocyclopropane-1-carboxylic Acid
Woodard, Ronald W.
, p. 4796 - 4799 (2007/10/02)
The two enantiomeric methylene carbons of 1-aminocyclopropane-1-carboxylic acid (ACC) were differentiated by an NMR study.Several amino acids such as L-alanine, D-alanine, and 2-aminoisobutyric acid as well as ACC were condensed with L- and/or D-phenylala
